180 related articles for article (PubMed ID: 11762339)
1. Oncogenes, growth factors, receptor expression and proliferation markers in digestive neuroendocrine tumours. A critical reappraisal.
Delle Fave G; Corleto VD
Ann Oncol; 2001; 12 Suppl 2():S13-7. PubMed ID: 11762339
[TBL] [Abstract][Full Text] [Related]
2. Tumour biology of gastroenteropancreatic neuroendocrine tumours.
Grötzinger C
Neuroendocrinology; 2004; 80 Suppl 1():8-11. PubMed ID: 15477708
[TBL] [Abstract][Full Text] [Related]
3. Molecular insights into gastrointestinal neuroendocrine tumours: importance and recent advances.
Corleto VD; Delle Fave G; Jensen RT
Dig Liver Dis; 2002 Sep; 34(9):668-80. PubMed ID: 12405256
[TBL] [Abstract][Full Text] [Related]
4. Somatostatin receptors in gastroentero-pancreatic neuroendocrine tumours.
de Herder WW; Hofland LJ; van der Lely AJ; Lamberts SW
Endocr Relat Cancer; 2003 Dec; 10(4):451-8. PubMed ID: 14713257
[TBL] [Abstract][Full Text] [Related]
5. Biology, diagnosis, and treatment of neuroendocrine tumors of the gastrointestinal tract.
Oberg K
Curr Opin Oncol; 1994 Jul; 6(4):441-51. PubMed ID: 7803546
[TBL] [Abstract][Full Text] [Related]
6. [The somatostatin receptor family--a window against new diagnosis and therapy of cancer].
Hofsli E
Tidsskr Nor Laegeforen; 2002 Feb; 122(5):487-91. PubMed ID: 11961977
[TBL] [Abstract][Full Text] [Related]
7. Review article: The role of oncogenes, tumour suppressor genes and growth factors in oral squamous cell carcinoma: a case of apoptosis versus proliferation.
Sugerman PB; Joseph BK; Savage NW
Oral Dis; 1995 Sep; 1(3):172-88. PubMed ID: 8705824
[TBL] [Abstract][Full Text] [Related]
8. Peptide receptors in gut endocrine tumours.
de Herder WW; Hofland LJ; van der Lely AJ; Lamberts SW
Baillieres Clin Gastroenterol; 1996 Dec; 10(4):571-87. PubMed ID: 9113313
[TBL] [Abstract][Full Text] [Related]
9. Tumor suppressor genes in the 9p21 gene cluster are selective targets of inactivation in neuroendocrine gastroenteropancreatic tumors.
Lubomierski N; Kersting M; Bert T; Muench K; Wulbrand U; Schuermann M; Bartsch D; Simon B
Cancer Res; 2001 Aug; 61(15):5905-10. PubMed ID: 11479232
[TBL] [Abstract][Full Text] [Related]
10. Biological and molecular aspects of gastroenteropancreatic neuroendocrine tumors.
Rindi G; Villanacci V; Ubiali A
Digestion; 2000; 62 Suppl 1():19-26. PubMed ID: 10940683
[TBL] [Abstract][Full Text] [Related]
11. Analysis of molecular pathways in neuroendocrine cancers of the gastroenteropancreatic system.
Arnold CN; Sosnowski A; Blum HE
Ann N Y Acad Sci; 2004 Apr; 1014():218-9. PubMed ID: 15153437
[TBL] [Abstract][Full Text] [Related]
12. Oncogenic co-operation in beta-cell tumorigenesis.
Pelengaris S; Khan M
Endocr Relat Cancer; 2001 Dec; 8(4):307-14. PubMed ID: 11733227
[TBL] [Abstract][Full Text] [Related]
13. Molecular aspects of the endocrine tumours of the pancreas and the gastrointestinal tract.
Rindi G; Candusso ME; Solcia E
Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S135-8. PubMed ID: 10604117
[TBL] [Abstract][Full Text] [Related]
14. [Expression and co-expression of cellular oncogenes in the course of tumor progression in neuroendocrine lung tumors].
Kogan EA; Shtabskiĭ AB; Sekamova SM; Sukhova NM; Mazurenko NN
Arkh Patol; 1994; 56(2):16-21. PubMed ID: 8037585
[TBL] [Abstract][Full Text] [Related]
15. Biological prognostic factors in non-small cell lung cancer.
Scagliotti GV; Masiero P; Pozzi E
Lung Cancer; 1995 Apr; 12 Suppl 1():S13-25. PubMed ID: 7551921
[TBL] [Abstract][Full Text] [Related]
16. Molecular aspects of chemical carcinogenesis: the roles of oncogenes and tumour suppressor genes.
Stanley LA
Toxicology; 1995 Feb; 96(3):173-94. PubMed ID: 7900159
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic and prognostic tumor markers in the gastrointestinal tract.
Seregni E; Ferrari L; Martinetti A; Bombardieri E
Semin Surg Oncol; 2001 Mar; 20(2):147-66. PubMed ID: 11398208
[TBL] [Abstract][Full Text] [Related]
18. New molecular aspects in the diagnosis and therapy of neuroendocrine tumors of the gastroenteropancreatic system.
Pape UF; Höcker M; Seuss U; Wiedenmann B
Recent Results Cancer Res; 2000; 153():45-60. PubMed ID: 10626288
[TBL] [Abstract][Full Text] [Related]
19. Rap1/B-Raf signaling is activated in neuroendocrine tumors of the digestive tract and Raf kinase inhibition constitutes a putative therapeutic target.
Karhoff D; Sauer S; Schrader J; Arnold R; Fendrich V; Bartsch DK; Hörsch D
Neuroendocrinology; 2007; 85(1):45-53. PubMed ID: 17341847
[TBL] [Abstract][Full Text] [Related]
20. Oncogene protein co-expression. Value of Ha-ras, c-myc, c-fos, and p53 as prognostic discriminants for breast carcinoma.
Bland KI; Konstadoulakis MM; Vezeridis MP; Wanebo HJ
Ann Surg; 1995 Jun; 221(6):706-18; discussion 718-20. PubMed ID: 7794075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
